Similar articles

• Prevalence of mucoid strains of Pseudomonas aeruginosa in bacteriological specimens from patients with cystic fibrosis and patients with other diseases.

  Hoiby N. Hoiby N. Acta Pathol Microbiol Scand Suppl. 1975 Dec;83(6):549-52. Acta Pathol Microbiol Scand Suppl. 1975. PMID: 812334
• Biofilm dispersal and exacerbations of cystic fibrosis lung disease.

  Reid DW, Kirov SM, Webb JS, Carroll V, Kjelleberg S, Champion A, Sanderson K. Reid DW, et al. Pediatr Pulmonol. 2006 Dec;41(12):1254; author reply 1255. doi: 10.1002/ppul.20420. Pediatr Pulmonol. 2006. PMID: 17068827 No abstract available.
• Mucoid Escherichia coli in cystic fibrosis.

  Macone AB, Pier GB, Pennington JE, Matthews WJ Jr, Goldmann DA. Macone AB, et al. N Engl J Med. 1981 Jun 11;304(24):1445-9. doi: 10.1056/NEJM198106113042401. N Engl J Med. 1981. PMID: 6785645
• Infections with Pseudomonas aeruginosa in patients with cystic fibrosis.

  Tümmler B, Bosshammer J, Breitenstein S, Brockhausen I, Gudowius P, Herrmann C, Herrmann S, Heuer T, Kubesch P, Mekus F, Römling U, Schmidt KD, Spangenberg C, Walter S. Tümmler B, et al. Behring Inst Mitt. 1997 Feb;(98):249-55. Behring Inst Mitt. 1997. PMID: 9382747 Review.
• Microbiological background for anti-Pseudomonas aeruginosa vaccination in cystic fibrosis.

  Bauernfeind A, Przyklenk B. Bauernfeind A, et al. Behring Inst Mitt. 1997 Feb;(98):256-61. Behring Inst Mitt. 1997. PMID: 9382748 Review. No abstract available.